1. Home
  2. ANL vs SD Comparison

ANL vs SD Comparison

Compare ANL & SD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$9.36

Market Cap

611.1M

Sector

N/A

ML Signal

HOLD

Logo SandRidge Energy Inc.

SD

SandRidge Energy Inc.

HOLD

Current Price

$13.19

Market Cap

517.6M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANL
SD
Founded
2004
2006
Country
United States
United States
Employees
109
N/A
Industry
Oil & Gas Production
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
611.1M
517.6M
IPO Year
2022
2006

Fundamental Metrics

Financial Performance
Metric
ANL
SD
Price
$9.36
$13.19
Analyst Decision
Strong Buy
Strong Sell
Analyst Count
1
1
Target Price
$20.00
$15.00
AVG Volume (30 Days)
144.9K
320.4K
Earning Date
04-10-2026
05-05-2026
Dividend Yield
N/A
3.07%
EPS Growth
N/A
12.43
EPS
N/A
0.50
Revenue
N/A
N/A
Revenue This Year
$36.02
$12.65
Revenue Next Year
N/A
$1.75
P/E Ratio
N/A
$26.48
Revenue Growth
N/A
N/A
52 Week Low
$0.88
$9.89
52 Week High
$17.25
$18.45

Technical Indicators

Market Signals
Indicator
ANL
SD
Relative Strength Index (RSI) 40.75 34.28
Support Level $9.46 $11.14
Resistance Level $9.98 $15.80
Average True Range (ATR) 1.35 0.39
MACD 0.05 -0.07
Stochastic Oscillator 27.46 9.00

Price Performance

Historical Comparison
ANL
SD

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

About SD SandRidge Energy Inc.

SandRidge Energy Inc is a United States-based oil and natural gas company. It is engaged in the exploration, development, and production of crude oil, natural gas, and Natural gas liquids. Business activities of the group include Exploration and Production, Drilling and Oil Field Services, and Midstream Gas Services. The company's primary areas of operation are the Mid-Continent in Oklahoma and Kansas.

Share on Social Networks: